HIMS: Second round!HIMS: Second round!
-Inversed HnS pattern has broken out successfully and now backtest.
-ABCD pattern.
-Golden fibo zone support.
-Demand zone support.
-Less vol pullback.
See more plans at US STOCKS- WALL STREET DREAM
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.47 USD
−23.55 M USD
872.00 M USD
177.41 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
FIGI
BBG00Q53VYM7
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS: Another buying opportunity! 88% UpsideCharturday #4: NYSE:HIMS 💊
A top 3 trade/ investment for me right now!
Weekly Analysis:
-H5 Indicator is GREEN
-Broke out of Bull Flag and realized $35 MM
-Broke out of CupnHandle and now retesting before we head towards our $48.55 measured move (MM). Already wicked off the area which shows con
Another Buying Opportunity on $HIMS! 60% UpsideNYSE:HIMS 💊
We are only half way through the week and this is me telling you that THIS IS ANOTHER BUYING OPPORTUNITY!
I said the same thing when we had the Short Attack and flush to $19.
What you don't realize is that the Wr% at the top of the chart ran up into the barrier of the Williams Cons
$HIMS UPDATE! You asked, I delivered! 60% UpsideNYSE:HIMS UPDATE! You asked, I delivered! 60% Upside
In this video, we will discuss:
-Why NYSE:HIMS is pulling back this week
-Short/Long-term targets
-What the H5 and WCB strategies are telling us
-and more...
NFA
Check it out!
HIMS - Elliot 'C' Wave Short HIMS has reached its A wave retrace of >.786 (i.e. 'B' wave is complete). Started short today. Will cover short when price < $19, or price > $31.
HIMS - 30% UP ?HIMS - Cup & Handle pattern + Above the average line 150. Only an idea and not a recommendation for trading
HIMS Monthly cup and handleTarget is around $50 for 2025. Good revenue with projected growth so the target of $50 is reachable earlier in mid of 2025, but if bad approval news comes up, we may see slow reaching to the target.
HIMS bounce or dive ?HIMS looking like bouncing off the 50 da MA very nicely as highlighted previously
If it does then 32 is a top again
Entry now : 24 25
Stop loss 22
Bullish Roll Up, It’s Just The Start!
- Bullish Financials: Q3 showed a 77% YoY revenue growth and over 1000% increase in net profit, signaling robust financial health.
- Product Expansion: New categories are driving up order rates and revenue per user, potentially increasing the stock's valuation.
- Customer Engagement: High persona
HIMS Bullish Morning VolumeOver the last five days, HIMS has shown consistent high trading volume in the morning sessions, often accompanied by bullish momentum and large green candlesticks, indicating strong buying interest likely driven by premarket news or institutional activity. This bullish sentiment has repeatedly pushe
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 26.20 USD — it has decreased by −0.61% in the past 24 hours. Watch Hims & Hers Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
HIMS stock has fallen by −11.84% compared to the previous week, the month change is a 13.67% rise, over the last year Hims & Hers Health, Inc. has showed a 211.53% increase.
We've gathered analysts' opinions on Hims & Hers Health, Inc. future price: according to them, HIMS price has a max estimate of 42.00 USD and a min estimate of 18.00 USD. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. stock forecast: see what analysts think of Hims & Hers Health, Inc. and suggest that you do with its stocks.
HIMS reached its all-time high on Nov 27, 2024 with the price of 35.02 USD, and its all-time low was 2.72 USD and was reached on May 12, 2022. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 7.19% volatile and has beta coefficient of 3.92. Track Hims & Hers Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. there?
Today Hims & Hers Health, Inc. has the market capitalization of 5.72 B, it has increased by 3.08% over the last week.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 0.32 USD per share, whereas the estimation was 0.11 USD resulting in a 187.74% surprise. The estimated earnings for the next quarter are 0.18 USD per share. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 401.56 M USD, despite the estimated figure of 382.20 M USD. In the next quarter, revenue is expected to reach 469.32 M USD.
HIMS net income for the last quarter is 75.59 M USD, while the quarter before that showed 13.30 M USD of net income which accounts for 468.46% change. Track more Hims & Hers Health, Inc. financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 1.05 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is 50.21 M USD, and current EBITDA margin is −2.75%. See more stats in Hims & Hers Health, Inc. financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. stock shows the buy signal. See more of Hims & Hers Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.